Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Hyperfine, Inc.

HYPR Clue Score60
United States Fiscal year ends December CIK 0001833769 Results filed 8 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Brett Hale
24 Aug 2026
CFO and CAO
Sell
7,345
$0.85
$6.27K
Thomas Teisseyre
24 Aug 2026
Chief Operating Officer
Sell
7,345
$0.85
$6.27K
Thomas Teisseyre
26 May 2026
Chief Operating Officer
Sell
6,047
$1.65
$9.98K
Brett Hale
26 May 2026
CFO and CAO
Sell
6,047
$1.65
$9.98K
Brett Hale
23 Mar 2026
CFO and CAO
Sell
24,188
$1.21
$29.27K
Thomas Teisseyre
23 Mar 2026
Chief Operating Officer
Sell
24,188
$1.21
$29.27K
Thomas Teisseyre
13 Feb 2026
Chief Operating Officer
Sell
821
$1.11
$912.54
Thomas Teisseyre
19 Nov 2025
Chief Operating Officer
Sell
1,405
$1.08
$1.52K

What was left out

Form 4 filings counted 16
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 1,410,000
History held since 23 Dec 2021